Inhibitory effects of armepavine against hepatic fibrosis in rats

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Weng, Ting Chun ^a   Shen, Chien Chang ^b   Chiu, Yung Tsung ^c   Lin, Yun Lian ^b   Kuo, Cheng Deng ^d   Huang, Yi Tsau ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; ARMEPAVINE; ASPARTATE AMINOTRANSFERASE; COLLAGEN; COLLAGEN TYPE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; ACTIN; BENZYLISOQUINOLINE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BLOOD SAMPLING; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CELL; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BILIARY CIRRHOSIS; BIOSYNTHESIS; BLOOD; CELL LINE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL LIVER CIRRHOSIS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; NELUMBO; PATHOLOGY; PHOSPHORYLATION; PHYTOTHERAPY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; STELLATE CELL; ULTRASTRUCTURE;

MUS; NELUMBO NUCIFERA; RATTUS;

ACTINS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZYLISOQUINOLINES; CELL LINE; COLLAGEN; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS, BILIARY; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MAP KINASE SIGNALING SYSTEM; NELUMBO; NF-KAPPA B; PHOSPHORYLATION; PHYTOTHERAPY; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349136709     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-78     Document Type: Article

References (48)

1. Mechanisms of hepatic fibrogenesis. SL Friedman, Gastroenterology 2008 134 1655 1669 10.1053/j.gastro.2008.03.003 18471545
2. Mechanisms of fibrogenesis. T Kisseleva DA Brenner, Exp Biol Med 2008 233 109 122 10.3181/0707-MR-190 (Pubitemid 351231543)
3. Liver fibrosis: cellular mechanisms of progression and resolution. NC Henderson JP Iredale, Clin Sci 2007 112 265 280 10.1042/CS20060242 17261089
4. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. SL Friedman, Physiol Rev 2008 88 125 172 10.1152/physrev.00013.2007 18195085
5. Liver fibrosis. K Wallace AD Burt MC Wright, Biochem J 2008 411 1 18 10.1042/BJ20071570 18333835
6. Circuitry of NF-B signaling. A Hoffmann D Baltimore, Immunol Rev 2006 210 171 186 10.1111/j.0105-2896.2006.00375.x 16623771
7. NF-B and the hepatic inflammation- fibrosis-cancer axis. AM Elsharkawy DA Mann, Hepatology 2007 46 590 597 10.1002/hep.21802 17661407
8. NF-B and cancer-identifying targets and mechanisms. WE Naugler M Karin, Curr Opin Genet Dev 2008 18 19 26 10.1016/j.gde.2008.01.020 18440219
9. Cytokines induce NF-B in activated but not in quiescent rat hepatic stellate cells. C Hellerbrand C Jobin LL Licato RB Sartor DA Brenner, Am J Physiol 1998 275 269 G278 9688654
10. NF-B in proliferation, activation, and apoptosis in rat hepatic stellate cells. A Lang R Schoonhoven S Tuvia DA Brenner RA Rippe, J Hepatol 2000 33 49 58 10.1016/S0168-8278(00)80159-2 10905586
11. Nelumbo nucifera (Gaertn). W Tang G Eisenbrand, Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine Berlin: Springer-Verlag 1992 697 701
12. Antioxidant activity of Nelumbo nucifera (sacred lotus) seeds. S Rai A Wahile K Mukherjee BP Saha PK Mukherjee, J Ethnopharmacol 2006 104 322 327 10.1016/j.jep.2005.09.025 16239089
13. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice. CP Liu WJ Tsai CC Shen YL Lin JF Liao CF Chen YC Kuo, Eur J Pharmacol 2006 531 270 279 10.1016/j.ejphar.2005.11.062 16413531
14. Hepatoprotective and free radical scavenging effects of Nelumbo nucifera. DH Sohn YC Kim SH Oh EJ Park X Li BH Lee, Phytomedicine 2003 10 165 169 10.1078/094471103321659889 12725571
15. Isolation, characterization, and determination of antioxidative activity of oligomeric procyanidins from the seedpod of Nelumbo nucifera Gaertn. ZQ Ling BJ Xie EL Yang, J Agri Food Chem 2005 53 2441 2445 10.1021/jf040325p (Pubitemid 40471722)
16. The extracts from Nelumbo Nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells. CP Liu WJ Tsai YL Lin JF Liao CF Chen YC Kuo, Life Sci 2004 75 699 716 10.1016/j.lfs.2004.01.019 15172179
17. (S)-Armepavine inhibits human peripheral blood mononuclear cell activation by regulating Itk and PLC activation in a PI-3K-dependent manner. CP Liu YC Kuo CC Shen MH Wu JF Liao YL Lin CF Chen WJ Tsai, J Leukoc Biol 2007 81 1276 1286 10.1189/jlb.0106056 17284681
18. Armepavine oxalate induces cell death on CCRF-CEM leukemia cell line through an apoptotic pathway. GM Jow YC Wu JH Guh CM Teng, Life Sci 2004 75 549 557 10.1016/S0024-3205(04)00269-3 15158365
19. Oxidative stress related changes in the liver of bile duct ligated rats. YT Huang YC Hsu CJ Chen CT Liu YH Wei, J Biomed Sci 2003 10 170 178 10.1007/BF02256052 12595753
20. Anti-fibrotic effects of tetrandrine on bile-duct ligated rats. YC Hsu YT Chiu CY Lee CF Wu YT Huang, Can J Physiol Pharmacol 2006 84 967 976 10.1139/Y06-050 17218962
21. Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine- intoxicated rats. LW Chong YC Hsu YT Chiu KC Yang YT Huang, J Biomed Sci 2006 13 403 418 10.1007/s11373-006-9079-5 16604421
22. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis. YC Hsu YT Chiu CC Cheng CF Wu YL Lin YT Huang, J Gastroenterol Hepatol 2007 22 99 111 10.1111/j.1440-1746.2006.04361.x 17201889
23. Anti-lymphoproliferative alkaloids from Plumula nelumbinis. WY Wang CP Liu YC Kuo YL Lin, Chin Pharm J 2004 56 25 30
24. An immortalized rat liver stellate cell (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. S Vogel R Piantedosi J Frnak A Lalazar DC Rockey SL Friedman WS Blaner, J Lipid Res 2000 41 882 893 10828080
25. Studies on antiproliferative effects of phthalides from Ligusticum chuanxiong in hepatic stellate cells. TF Lee YL Lin YT Huang, Planta Med 2007 73 527 534 10.1055/s-2007-981520 17520522
26. Inhibitory effects of Ligusticum chuanxiong on the proliferation of rat hepatic stellate cells. YL Lin TF Lee YT Huang, J Gastroenterol Hepatol 2006 21 1257 1265 10.1111/j.1440-1746.2006.04326.x 16872306
27. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. A Lopez-De Leon M Rojkind, J Histochem Cytochem 1985 33 737 743 2410480
28. Classification of chronic viral hepatitis: a need for reassessment. PJ Scheuer, J Hepatol 1991 13 372 374 10.1016/0168-8278(91)90084-O 1808228
29. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine- intoxicated rats. YC Hsu YL Lin YT Chiu MS Shiao CY Lee YT Huang, J Biomed Sci 2005 12 185 195 10.1007/s11373-004-8167-7 15864749
30. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. P Chomczynski N Sacchi, Anal Biochem 1987 162 156 159 10.1016/0003-2697(87)90021-2 2440339
31. Redox signals and NF-kappaB activation in T cells. ME Ginn-Pease RL Whisler, Free Rad Biol Med 1998 25 346 361 10.1016/S0891-5849(98)00067-7 9680181
32. Herbal products for liver diseases: a therapeutic challenge for the new millennium. D Schuppan JD Jia B Brinkhaus EG Hahn, Hepatology 1999 30 1099 1104 10.1002/hep.510300437 10498665
33. The use of silymarin in the treatment of liver diseases. R Saller R Meier R Brignoli, Drugs 2001 61 2035 2063 10.2165/00003495-200161140-00003 11735632
34. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1. JD Jia M Bauer JJ Cho M Ruehl S Milani G Boigk EO Riecken D Schuppan, J Hepatol 2001 35 392 398 10.1016/S0168-8278(01)00148-9 11592601
35. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. G Boigk L Stroedter H Herbst J Waldschmidt EO Riecken D Schuppan, Hepatology 1997 26 643 649 10.1002/hep.510260316 9303494
36. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. J Kountouras BH Billing PJ Scheuer, J Exp Pathol 1984 65 305 311
37. Regulatory role of metallothionein in NFB. A Sakurai S Hara N Okano Y Kondo J Inoue N Imura, FEBS Letts 1999 445 55 58 10.1016/S0014-5793(99)00839-X (Pubitemid 29322781)
38. Metallothionein gene therapy for chemical-induced liver fibrosis in mice. Y Jiang YJ Kang, Mol Ther 2004 10 1130 1139 10.1016/j.ymthe.2004.08.011 15564144
39. Differential regulation and properties of MAPKs. M Raman W Chen MH Cobb, Oncogene 2007 26 3100 3112 10.1038/sj.onc.1210392 17496909
40. Mitogen-activated protein kinases in heart development and diseases. Y Wang, Circulation 2007 116 1413 23 10.1161/CIRCULATIONAHA.106.679589 17875982
41. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. C Bubici S Papa K Dean G Franzoso, Oncogene 25 6731 6748 10.1038/sj.onc.1209936 17072325
42. Sho-saiko-to, Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. I Shimizu, J Gastroenterol Hepatol 2000 15 Suppl 84 D90 10.1046/j.1440-1746.2000.02138.x 10759225
43. Oxidative stress, plant-derived antioxidants and liver fibrosis. R Gebhardt, Planta Med 2002 68 289 296 10.1055/s-2002-26761 11988849
44. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. I Shimizu Y-R Ma Y Mizobuchi F Liu T Miura Y Nakai M Yasuda M Shiba T Horie S Amagaya N Kawada H Hori S Ito, Hepatology 1999 29 149 160 10.1002/hep.510290108 9862861
45. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-deficient diet. I Sakaida Y Matsumura S Akiyama K Hayashi A Ishige K Okita, J Hepatol 1998 28 298 306 10.1016/0168-8278(88)80017-5 9514543
46. Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-deficient diet. I Sakaida M Tsuchiya K Kawaguchi T Kimura S Terai K Okita, J Hepatol 2003 38 762 9 10.1016/S0168-8278(03)00094-1 12763369
47. Salvia miltiorrhiza reduced experimentally-induced hepatic fibrosis in rats. S Wasser JMS Ho HK Ang CEL Tan, J Hepatol 1998 29 760 771 10.1016/S0168-8278(98)80257-2 9833914
48. 4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Y Fu S Zheng J Lin J Ryerse A Chen, Mol Pharmacol 2008 73 399 409 10.1124/mol.107.039818 18006644